11/26
07:28 am
pmn
ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference [Canadian Business Journal (Canada)]
Low
Report
ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference [Canadian Business Journal (Canada)]
11/26
07:05 am
pmn
ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference [Yahoo! Finance]
Low
Report
ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference [Yahoo! Finance]
11/26
07:00 am
pmn
ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference
Low
Report
ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference
11/14
09:15 am
pmn
ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights
Low
Report
ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights
11/12
07:28 am
pmn
ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference [Canadian Business Journal (Canada)]
Medium
Report
ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference [Canadian Business Journal (Canada)]
11/12
07:00 am
pmn
ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
Medium
Report
ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
10/30
08:09 am
pmn
ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer's Disease Conference [Financial Post (Toronto, Ontario, Canada)]
Medium
Report
ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer's Disease Conference [Financial Post (Toronto, Ontario, Canada)]
10/30
08:00 am
pmn
ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer’s Disease Conference
Low
Report
ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer’s Disease Conference
10/13
03:00 pm
pmn
ProMIS Neurosciences, Inc. (PMN): Analysts Are Bullish On This Undervalued Canadian Stock Now [Yahoo! Finance]
Low
Report
ProMIS Neurosciences, Inc. (PMN): Analysts Are Bullish On This Undervalued Canadian Stock Now [Yahoo! Finance]